This inventor holds 61 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents, primarily in Immunomodulators (CPC class C07D). Top assignees: Abbott Laboratories Corporation, Millennium Pharmaceuticals Limited, Kyowa Hakko Kirin Co., Limited. Active years: 1987-2018.
Inventors with similar research interests:
Location History:
- Lake Bluff, IL (US) (1987)
- Liverty Ville, IL (US) (1995)
- Libertyville, IL (US) (1987 - 1998)
- Wellesley, MA (US) (2000 - 2018)
Company Filing History:
40 out of 4,186 
6 out of 854 
3 out of 272 
Years Active: 1987-2018
Areas of Expertise:
Title: Jay R Luly: A Pioneer in Pharmaceutical Innovations
Introduction
Jay R Luly, based in Libertyville, IL, is a prominent figure in the pharmaceutical industry, recognized for his significant contributions to drug development. With an impressive portfolio of 61 patents, Luly has made substantial advancements in creating compounds aimed at treating viral infections, amongst other pharmaceutical applications.
Latest Patents
Among his latest innovations, Luly has developed compounds represented by specific formulas that include pharmaceutically acceptable salts, esters, stereoisomers, tautomers, solvates, and combinations thereof. These compounds have been designed for treating viral infections in subjects. Additionally, he has introduced deuterated nucleoside/tide derivatives, providing nucleoside phosphoramidate compounds and pharmaceutical compositions which offer methods of use for tackling viral infections.
Career Highlights
Throughout his career, Jay R Luly has collaborated with leading organizations, including Abbott Laboratories Corporation. His expertise and innovative approach have allowed him to contribute to the development of effective pharmaceutical solutions, impacting the medical field significantly.
Collaborations
Luly has worked alongside esteemed colleagues such as Yat Sun Or and Megumi Kawai. Their collective efforts have fueled innovations in the pharmaceutical landscape, as they strive to develop advanced treatments for critical health issues.
Conclusion
With a strong focus on innovation and collaboration, Jay R Luly continues to push the boundaries of pharmaceutical science. His extensive patent portfolio reflects his commitment to advancing healthcare solutions and addressing the challenges posed by viral infections.